TY - JOUR
T1 - Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP)
AU - Rades, Dirk
AU - Bohlen, Guenther
AU - Lohynska, Radka
AU - Veninga, Theo
AU - Stalpers, Lukas J. A.
AU - Schild, Steven E.
AU - Dunst, Juergen
PY - 2007
Y1 - 2007
N2 - Whole brain radiotherapy (WBRT) is the most common treatment for brain metastases. Survival of patients with cancer of unknown primary (CUP) presenting with brain metastases is extremely poor. A radiation program with a short overall treatment time (short-course RT) would be preferable to longer programs if it provides similar outcomes. This study compares short-course RT with 20 Gy in 5 fractions (5 x 4 Gy) given over 5 days to longer programs in CUP patients. Data regarding 101 CUP patients who received either short course WBRT (n=34) with 5 x 4 Gy or long-course WBRT (n=67) with 10 x 3 Gy given over 2 weeks or 20 x 2 Gy given over 4 weeks for brain metastases were analyzed retrospectively. Six additional potential prognostic factors were investigated: age, gender, Karnofsky performance score (KPS), number of brain metastases, extracranial metastases, RPA-(Recursive Partitioning Analysis-)class. On univariate analysis, the radiation program was not associated with survival (p=0.88) nor intracerebral control (p=0.36). Improved survival was associated with KPS >or= 70 (p <0.001), absence of extracranial metastases (p <0.001), and RPA-class 1 (p <0.001). On multivariate analyses, KPS (risk ratio [RR]: 4.55; p <0.001), extracranial metastases (RR: 1.70; p=0.018), and RPA-class (RR: 2.86; p <0.001) maintained significance. On univariate analysis, KPS (p <0.001) and RPA-class (p <0.001) were significantly associated with intracerebral control. On multivariate analyses, KPS (RR: 2.72; p <0.001) and RPA-class (RR: 2.09; p <0.001) remained significant. Short-course WBRT with 5 x 4 Gy provided similar intracerebral control and survival as longer programs for the treatment of brain metastases in CUP patients. 5 x 4 Gy appears preferable because it is more convenient for patients
AB - Whole brain radiotherapy (WBRT) is the most common treatment for brain metastases. Survival of patients with cancer of unknown primary (CUP) presenting with brain metastases is extremely poor. A radiation program with a short overall treatment time (short-course RT) would be preferable to longer programs if it provides similar outcomes. This study compares short-course RT with 20 Gy in 5 fractions (5 x 4 Gy) given over 5 days to longer programs in CUP patients. Data regarding 101 CUP patients who received either short course WBRT (n=34) with 5 x 4 Gy or long-course WBRT (n=67) with 10 x 3 Gy given over 2 weeks or 20 x 2 Gy given over 4 weeks for brain metastases were analyzed retrospectively. Six additional potential prognostic factors were investigated: age, gender, Karnofsky performance score (KPS), number of brain metastases, extracranial metastases, RPA-(Recursive Partitioning Analysis-)class. On univariate analysis, the radiation program was not associated with survival (p=0.88) nor intracerebral control (p=0.36). Improved survival was associated with KPS >or= 70 (p <0.001), absence of extracranial metastases (p <0.001), and RPA-class 1 (p <0.001). On multivariate analyses, KPS (risk ratio [RR]: 4.55; p <0.001), extracranial metastases (RR: 1.70; p=0.018), and RPA-class (RR: 2.86; p <0.001) maintained significance. On univariate analysis, KPS (p <0.001) and RPA-class (p <0.001) were significantly associated with intracerebral control. On multivariate analyses, KPS (RR: 2.72; p <0.001) and RPA-class (RR: 2.09; p <0.001) remained significant. Short-course WBRT with 5 x 4 Gy provided similar intracerebral control and survival as longer programs for the treatment of brain metastases in CUP patients. 5 x 4 Gy appears preferable because it is more convenient for patients
U2 - https://doi.org/10.1007/s00066-007-1763-5
DO - https://doi.org/10.1007/s00066-007-1763-5
M3 - Article
C2 - 17960339
SN - 0179-7158
VL - 183
SP - 631
EP - 636
JO - Strahlentherapie und Onkologie
JF - Strahlentherapie und Onkologie
IS - 11
ER -